Premium
Lymphadenectomy in stage‐III serous cystadenocarcinoma of the ovary
Author(s) -
Fukasawa H,
Kikkawa F,
Tamakoshi K,
Kawai M,
Arii Y,
Tomoda Y
Publication year - 1995
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(95)80014-x
Subject(s) - medicine , lymphadenectomy , serous cystadenocarcinoma , stage (stratigraphy) , serous fluid , cystadenocarcinoma , surgery , ovary , retrospective cohort study , survival rate , radiology , ovarian cancer , cancer , paleontology , biology
Objective: To elucidate the effects of lymphadenectomy on the prognosis for ovarian cancer. Method: A retrospective study of 69 patients with stage‐III serous cystadenoarcinoma was performed. Results: Among the 69 patients, 36 were not treated by lymphadenectomy. Both pelvic and para‐aortic lymphadenectomies were performed on 13 patients at the initial operation and on 11 at the second operation. The group (n = 13) treated by both pelvic and para‐aortic lymphadenectomies at the initial operation had a disease‐free survival rate that was significantly higher than the nonlymphadenectomy group (n = 36) or the group (n = 5) treated by pelvic or para‐aortic lymphadenectomy alone (P < 0.04). These 54 patients were subjected to multivariate analysis for lymphadenectomy at the initial operation, and a significant correlation was found between disease‐free survival rate and both pelvic and para‐aortic lymphadenectomies (P < 0.05). Conclusion: These results suggest that systematic lymphadenectomy can reduce the rate of recurrence.